Literature DB >> 7515134

Factors influencing the natural history of colorectal liver metastases.

R Stangl1, A Altendorf-Hofmann, R M Charnley, J Scheele.   

Abstract

Palliative treatment of unresectable colorectal liver metastases is common and often justified with reference to historical data on the natural history of the disease. However, in view of the improved diagnostic accuracy of modern imaging techniques, these previously published series do not provide sufficient guidance to judge the prognostic efficacy of palliative treatment. In the late 1970s we started prospectively to collect data on consecutive patients with colorectal liver metastases according to a standard protocol. We now present data derived from this series on factors that may affect outcome in untreated patients. Between January, 1980, and December, 1990, 1099 consecutive patients were recorded, of whom 566 (51.5%) received no treatment for their hepatic tumour. Excluding 34 early deaths and 48 patients with a second malignant tumour, 484 patients provided the basis for analysis. All patients were followed up to July 1, 1993, or death. At the closing date of the study only 1 untreated patient was still alive. The impact of various factors on survival was analysed by univariate and multivariate analyses. Six independent determinants of survival were identified in the following order: percentage liver volume replaced by tumour (LVRT), grade of malignancy of the primary tumour, presence of extrahepatic disease, mesenteric lymph-node involvement, serum carcino-embryonic antigen, and age. The subsequent combination of the independently significant factors, separately for patients with up to or more than 25% LVRT, yielded a prognostic tree that displayed median survival times of various subgroups of 3.8 to 21.3 months. These findings provide a framework to estimate the survival expectancy of untreated patients, thereby allowing improved assessment of the prognostic significance of palliative therapeutic approaches.

Entities:  

Mesh:

Year:  1994        PMID: 7515134     DOI: 10.1016/s0140-6736(94)92529-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  178 in total

1.  Radiofrequency ablation for colorectal liver metastases: prognostic factors in non-surgical candidates.

Authors:  Ayumi Hamada; Koichiro Yamakado; Atsuhiro Nakatsuka; Junji Uraki; Masataka Kashima; Haruyuki Takaki; Takashi Yamanaka; Yasuhiro Inoue; Masato Kusunoki; Kan Takeda
Journal:  Jpn J Radiol       Date:  2012-06-05       Impact factor: 2.374

Review 2.  "Vanishing liver metastases"-A real challenge for liver surgeons.

Authors:  Alex Zendel; Eylon Lahat; Yael Dreznik; Barak Bar Zakai; Rony Eshkenazy; Arie Ariche
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

3.  Resectability of colorectal liver metastases: an evolving definition.

Authors:  Flavio G Rocha; W Scott Helton
Journal:  HPB (Oxford)       Date:  2012-03-19       Impact factor: 3.647

4.  Assessment of liver metastases from colorectal adenocarcinoma following chemotherapy: SPIO-MRI versus FDG-PET/CT.

Authors:  L Bacigalupo; S Aufort; M C Eberlé; E Assenat; M Ychou; B Gallix
Journal:  Radiol Med       Date:  2010-06-23       Impact factor: 3.469

5.  Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: a multicenter phase II study by the Cancer Therapeutic Research Group.

Authors:  Wing M Ho; B Ma; Tony Mok; W Yeo; Paul Lai; R Lim; Jane Koh; Y Y Wong; Ann King; C K Leow; A T C Chan
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

6.  Alteration of Drug Sensitivity in Human Colon Cancer Cells after Exposure to Heat: Implications for Liver Metastasis Therapy using RFA and Chemotherapy.

Authors:  Ryouji Makizumi; Weng-Lang Yang; Randall P Owen; Rohit R Sharma; T S Ravikumar
Journal:  Int J Clin Exp Med       Date:  2008-02-28

7.  Prognostic value of serum neutrophil gelatinase-associated lipocalin in metastatic and nonmetastatic colorectal cancer.

Authors:  Josep Martí; Josep Fuster; Anna M Solà; Georgina Hotter; Rafael Molina; Amalia Pelegrina; Joana Ferrer; Ramon Deulofeu; Constantino Fondevila; Juan Carlos García-Valdecasas
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

Review 8.  Pulmonary metastasectomy: a common practice based on weak evidence.

Authors:  Tom Treasure
Journal:  Ann R Coll Surg Engl       Date:  2007-11       Impact factor: 1.891

9.  Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

Authors:  René Adam; Gerard Pascal; Denis Castaing; Daniel Azoulay; Valerie Delvart; Bernard Paule; Francis Levi; Henri Bismuth
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

10.  Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients.

Authors:  Timothy M Pawlik; Francesco Izzo; Deborah S Cohen; Jeffery S Morris; Steven A Curley
Journal:  Ann Surg Oncol       Date:  2003-11       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.